UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration

Digestive diseases and sciences, 2018-09, Vol.63 (9), p.2259-2266

2018

Volltextzugriff (PDF)

Comedications alter drug-induced liver injury reporting frequency: Data mining in the WHO VigiBase

Regulatory toxicology and pharmacology, 2015-08, Vol.72 (3), p.481-490

2015

Volltextzugriff (PDF)

Genetic characterization to improve interpretation and clinical management of hepatotoxicity caused by tyrosine kinase inhibitors

Pharmacogenomics, 2013-04, Vol.14 (5), p.541-554

2013

Volltextzugriff (PDF)

Pharmacogenetic variants and risk of remdesivir‐associated liver enzyme elevations in Million Veteran Program participants hospitalized with COVID‐19

Clinical and translational science, 2022-08, Vol.15 (8), p.1880-1886

2022

Volltextzugriff (PDF)

One ALT Is Not Like the Other

Gastroenterology (New York, N.Y. 1943), 2023-08, Vol.165 (2), p.320-323

2023

Volltextzugriff (PDF)

Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration

World journal of gastroenterology : WJG, 2016-05, Vol.22 (19), p.4732-4740

2016

Volltextzugriff (PDF)

Drug rechallenge following drug‐induced liver injury

Hepatology (Baltimore, Md.), 2017-08, Vol.66 (2), p.646-654

2017

Volltextzugriff (PDF)

Expanding our toolkit to better identify drug‐induced liver injury in electronic medical records

Liver international, 2018-04, Vol.38 (4), p.585-587

Hunt, Christine M.

2018

Volltextzugriff (PDF)

An automated causality assessment algorithm to detect drug-induced liver injury in electronic medical record data

Pharmacoepidemiology and drug safety, 2014-06, Vol.23 (6), p.601-608

2014

Volltextzugriff (PDF)

Interplay of gender, age and drug properties on reporting frequency of drug-induced liver injury

Regulatory toxicology and pharmacology, 2018-04, Vol.94, p.101-107

2018

Volltextzugriff (PDF)

Characterizing phenotypes and outcomes of drug-associated liver injury using electronic medical record data

Pharmacoepidemiology and drug safety, 2013-02, Vol.22 (2), p.190-198

2013

Volltextzugriff (PDF)

Hepatitis B Virus-related Care Quality in Patients With Hepatitis B/Human Immunodeficiency Virus Coinfection Versus Hepatitis B Monoinfection: A National Cohort Study

Clinical infectious diseases, 2022-10, Vol.75 (9), p.1529-1536

2022

Volltextzugriff (PDF)

259 Proton pump inhibitor use is not significantly associated with severe COVID-19 related outcomes after extensive covariate adjustment

Journal of clinical and translational science, 2022-04, Vol.6 (s1), p.43-43

2022

Volltextzugriff (PDF)

Mitochondrial and immunoallergic injury increase risk of positive drug rechallenge after drug‐induced liver injury: A systematic review

Hepatology (Baltimore, Md.), 2010-12, Vol.52 (6), p.2216-2222

Hunt, Christine M.

2010

Volltextzugriff (PDF)

Clinical Pattern of Tolvaptan-Associated Liver Injury in Trial Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD): An Analysis of Pivotal Clinical Trials

American journal of kidney diseases, 2023-03, Vol.81 (3), p.281-293.e1

2023

Volltextzugriff (PDF)

Preventing Hepatitis B Reactivation During Anti‐CD20 Antibody Treatment in the Veterans Health Administration

Hepatology communications, 2018-09, Vol.2 (9), p.1136-1146

2018

Volltextzugriff (PDF)

Assessment of the Frequency, Phenotypes, and Outcomes of Acute Liver Injury Associated with Amoxicillin/Clavulanate in 1.4 Million Patients in the Veterans Health Administration

Drug safety, 2023-02, Vol.46 (2), p.129-143

2023

Volltextzugriff (PDF)

Medications Associated with Lower Mortality in a SARS-CoV-2 Positive Cohort of 26,508 Veterans

Journal of general internal medicine : JGIM, 2022-12, Vol.37 (16), p.4144-4152

2022

Volltextzugriff (PDF)

Age-related differences in reporting of drug-associated liver injury: Data-mining of WHO Safety Report Database

Regulatory toxicology and pharmacology, 2014-11, Vol.70 (2), p.519-526

2014

Volltextzugriff (PDF)

In Memoriam: Dawn Tranchino Provenzale, MD, MS (August 18, 1955–April 20, 2021)

Gastroenterology (New York, N.Y. 1943), 2022-03, Vol.162 (3), p.661-664

2022

Volltextzugriff (PDF)

Drugs Associated with Hepatotoxicity and their Reporting Frequency of Liver Adverse Events in VigiBase: Unified List Based on International Collaborative Work

Drug safety, 2010-06, Vol.33 (6), p.503-522

2010

Volltextzugriff (PDF)

Prevalence and incidence of liver enzyme elevations in a pooled oncology clinical trial cohort

Regulatory toxicology and pharmacology, 2016-06, Vol.77, p.257-262

2016

Volltextzugriff (PDF)

Children's liver chemistries vary with age and gender and require customized pediatric reference ranges

Regulatory toxicology and pharmacology, 2015-10, Vol.73 (1), p.349-355

2015

Volltextzugriff (PDF)

Alanine Aminotransferase Results Differ by Analyzer Manufacturer in a National Integrated Health Setting, 2012-2017

Archives of pathology & laboratory medicine (1976), 2020-06, Vol.144 (6), p.748-754

2020

Volltextzugriff (PDF)

COVID-19-Associated Mortality in US Veterans with and without SARS-CoV-2 Infection

International journal of environmental research and public health, 2021-08, Vol.18 (16), p.8486

2021

Volltextzugriff (PDF)

1 – 25 von 313

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(285)
Mit Volltextzugriff
(251)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(309)
Französisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration

Comedications alter drug-induced liver injury reporting frequency: Data mining in the WHO VigiBase

Genetic characterization to improve interpretation and clinical management of hepatotoxicity caused by tyrosine kinase inhibitors

Pharmacogenetic variants and risk of remdesivir‐associated liver enzyme elevations in Million Veteran Program participants hospitalized with COVID‐19

One ALT Is Not Like the Other

Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration

Drug rechallenge following drug‐induced liver injury

Expanding our toolkit to better identify drug‐induced liver injury in electronic medical records

An automated causality assessment algorithm to detect drug-induced liver injury in electronic medical record data

Interplay of gender, age and drug properties on reporting frequency of drug-induced liver injury

Characterizing phenotypes and outcomes of drug-associated liver injury using electronic medical record data

Hepatitis B Virus-related Care Quality in Patients With Hepatitis B/Human Immunodeficiency Virus Coinfection Versus Hepatitis B Monoinfection: A National Cohort Study

259 Proton pump inhibitor use is not significantly associated with severe COVID-19 related outcomes after extensive covariate adjustment

Mitochondrial and immunoallergic injury increase risk of positive drug rechallenge after drug‐induced liver injury: A systematic review

Clinical Pattern of Tolvaptan-Associated Liver Injury in Trial Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD): An Analysis of Pivotal Clinical Trials

Preventing Hepatitis B Reactivation During Anti‐CD20 Antibody Treatment in the Veterans Health Administration

Assessment of the Frequency, Phenotypes, and Outcomes of Acute Liver Injury Associated with Amoxicillin/Clavulanate in 1.4 Million Patients in the Veterans Health Administration

Medications Associated with Lower Mortality in a SARS-CoV-2 Positive Cohort of 26,508 Veterans

Age-related differences in reporting of drug-associated liver injury: Data-mining of WHO Safety Report Database

In Memoriam: Dawn Tranchino Provenzale, MD, MS (August 18, 1955–April 20, 2021)

Drugs Associated with Hepatotoxicity and their Reporting Frequency of Liver Adverse Events in VigiBase: Unified List Based on International Collaborative Work

Prevalence and incidence of liver enzyme elevations in a pooled oncology clinical trial cohort

Children's liver chemistries vary with age and gender and require customized pediatric reference ranges

Alanine Aminotransferase Results Differ by Analyzer Manufacturer in a National Integrated Health Setting, 2012-2017

COVID-19-Associated Mortality in US Veterans with and without SARS-CoV-2 Infection

Suchergebnisse filtern